WAVE Life Sciences

$1.27 0.00% ($0.00)

Get ready to invest

About WAVE Life Sciences

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.

Popular Stocks	Price	Change
Nu Holdings NU	$4.33 13.35%	13.35%
Annaly NLY	$6.27 1.42%	1.42%
AMD AMD	$96.67 0.41%	0.41%
Nvidia NVDA	$171.24 1.1%	1.1%
SoFi Technologies, Inc. SOFI	$7.75 7.19%	7.19%
Ford F	$12.85 0.55%	0.55%
Apple AAPL	$137.35 2.46%	2.46%
Cisco CSCO	$41.72 13.73%	13.73%
Grab Holdings inc. GRAB	$3.14 24.11%	24.11%
NIO NIO	$16.66 5.24%	5.24%